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Abstract  
Objectives 
To investigate the association between duration of rupture of membranes (ROM) and mother-to-
child HIV transmission (MTCT) rates in the era of combination antiretroviral therapy (cART). 
Design  
The National Study of HIV in Pregnancy and Childhood (NSHPC) undertakes comprehensive 
population-based surveillance of HIV in pregnant women and children. 
Setting 
UK and Ireland.  
Population or Sample 
2398 singleton pregnancies delivered vaginally or by emergency caesarean section in women on 
cART in pregnancy in 2007-2012 with information on duration of ROM; HIV infection status was 
available for 1898 infants.  
Methods 
Descriptive analysis of NSHPC data.  
Main Outcome Measures 
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MTCT rates. 
Results 
In 2116 pregnancies delivered at term, median duration of ROM was 3 hours 30 minutes (IQR: 1hr, 
8hr). The overall MTCT rate for women delivering at term with duration of ROM ≥4 hours was 0.64% 
compared with 0.34% for ROM <4 hours, with no significant difference between the groups (OR: 
1.90; 95% CI: 0.45, 7.97). In women delivering at term with viral load <50 copies/ml, there was no 
evidence of a difference in MTCT rates with duration of ROM ≥4 hours compared with <4 hours 
(0.14% for ≥4 hours versus 0.12% for <4 hour; OR: 1.14 (95% CI: 0.07, 18.27)). Among infants born 
preterm with infection status available, there were no transmissions in 163 deliveries where 
maternal viral load was ≤50 copies/ml. 
Conclusions 
No association was found between duration of ROM and MTCT in women taking cART.  
Keywords 
HIV, duration of ruptured membranes, mother-to-child transmission, pregnancy 
Twitter abstract 
Prolonged rupture of membranes is not associated with MTCT of HIV in women on effective ART 
delivering at term 
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Introduction  
Mother-to-child HIV transmission (MTCT) rates in Europe are now very low, and reached 0.57% 
among diagnosed women in the United Kingdom and Ireland in 2007-2011.1 In the era before 
combination antiretroviral therapy (cART) became widely available, elective caesarean section was 
shown to reduce the risk of MTCT compared with vaginal delivery.2,3 However, the success of cART in 
treating HIV has meant that, in the absence of obstetric contraindications, women with suppressed 
virus at delivery can now normally expect to have a vaginal delivery.4 
In the pre-cART era, several studies in untreated women or women receiving monotherapy indicated 
that prolonged rupture of membranes (ROM) was significantly associated with an increased risk of 
MTCT,5,6 while others suggested no association.7–9 A meta-analysis of 15 cohort studies suggested a 
2% increase in relative risk of transmission per hour of ROM, where duration of ROM was less than 
24 hours, but viral load was not considered.10 Evidence from the cART era is sparse: a small study in 
Spain found an increase in transmission rates in untreated but not in treated women with duration 
of ROM greater than 6 hours (compared with less than 6 hours),11 while a single-centre study in 
Miami found an association between MTCT and duration of ROM only where maternal viral load was 
greater than 1000 copies/ml.12   
For women with spontaneous ROM after 34 weeks gestation, current British guidelines recommend 
immediate induction of labour if maternal viral load is <50 copies/ml, consideration of immediate 
caesarean section if maternal viral load is 50-999 copies/ml, and immediate caesarean section if viral 
load is greater than 1000 copies/ml.4 Owing to the absence of data for  ROM in preterm deliveries at 
less than 34 weeks gestation, management is recommended on a case by case basis. There is 
currently no guidance relating to duration of ROM in women who are in active labour at term, also 
due to a lack of evidence. The aim of this analysis was to investigate the association between 
duration of ROM and MTCT rates in women on cART delivering in the UK and Ireland between 2007 
and 2012.  
Methods 
Comprehensive population-based data on HIV in pregnant women and children in the UK and Ireland 
are collected through the National Study of HIV in Pregnancy and Childhood, ongoing since 1990. 
Pregnancy and delivery data are provided by obstetric respondents, and information on duration of 
ROM has been collected since 2007. Infection status for all HIV-exposed infants is sought from 
paediatric respondents. Full details of methods are described elsewhere.1,13 
Mode of delivery was classified as elective caesarean section (pre-labour, pre-rupture of 
membranes), emergency caesarean section (after rupture of membranes and/or onset of labour, or 
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for other emergency obstetric indications), or vaginal delivery (reported by obstetric respondents as 
planned or unplanned). Duration of rupture of membranes is defined as the time between rupturing 
of the amniotic sac and delivery of the infant; due to limitations of data collection we were unable to 
further differentiate whether ROM occurred before or after the onset of labour, and whether this 
occurred spontaneously or was iatrogenic Maternal HIV viral load closest to delivery (during 
pregnancy or up to seven days postpartum) was selected and categorised as <50 (undetectable), 50-
399, 400-999, 1000-9999, and ≥10,000 copies/ml. Maternal CD4 cell count closest to delivery was 
classified as <200, 200-349, 350-499 and ≥500 cells/mm3. Gestation <37 weeks was classified as 
preterm, and <34 weeks as early preterm.  
Likely timing of infant infection was defined as: in utero where a positive HIV PCR was obtained 
within three days of birth; in utero/intrapartum where no PCR was reported within three days of 
birth, and a positive PCR between 3 days and 6 weeks of birth; intrapatrum where there was a 
negative PCR within 3 days of birth  and positive PCR within 6 weeks; intrapartum/postnatal where 
there was a negative PCR at within 3 days of birth but no positive PCR until after 6 weeks; and 
postnatal where there was a negative PCR between 4 days and 6 weeks and positive thereafter. 
Transmissions where testing did not fall into these groups were classified as unknown. 
Eligible pregnancies were all those reported by March 2013 in women diagnosed with HIV before 
delivery and on a combination of three or more antiretroviral drugs (cART) during pregnancy, who 
delivered singleton live-born infants between 1 January 2007 and 31 December 2012 in the UK and 
Ireland. Analyses were restricted to pregnancies where membranes were reported to have ruptured 
before delivery and duration of ROM was provided, and therefore all elective caesarean sections 
were excluded.  
Statistical Methods 
Data were managed in Access 2010 (Microsoft Corp., Redmond, Washington, USA), compiled using R 
version 2.14.214 and analysed using Stata version 12.1 (Stata Corp. LP, College Station, Texas, USA).  
Duration of ROM was classified as <4 hours, 4 to <24 hours, and ≥24 hours for descriptive purposes; 
MTCT rates in pregnancies with ROM <4 hours were compared with those with ROM ≥4 hours to 
facilitate comparison with other studies4,8,9,12. The low number of infected children, together with 
small numbers in certain groups, meant that multivariable analyses were not possible. 
Results 
Between 2007 and 2012 there were 7321 eligible pregnancies resulting in singleton live births to 
women diagnosed with HIV before or during pregnancy and on cART. We excluded pregnancies 
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delivered by elective caesarean section (2709/7321), missing mode of delivery (57/7321), births 
reported before ROM data were sought (131/7321) and deliveries by emergency caesarean where 
membranes were reported as ruptured only at delivery (616/7321). Duration of ROM was not stated 
for a further 19% (1410/7321) of the eligible pregnancies. The study population for analysis was 
therefore 2398 pregnancies (please see flow chart showing data inclusions and exclusions in 
supplementary figure S1) in 1814 women on cART with membranes ruptured before delivery and 
information on duration of ROM and HIV viral load near delivery.  
Baseline Characteristics 
Table 1 shows baseline characteristics of 2398 pregnancies. Almost 80% of pregnancies were in Black 
African women, and in three-quarters HIV infection was diagnosed prior to this pregnancy. Median 
interval from last reported HIV viral load to delivery was 22 days (IQR: 9, 37days). Overall, HIV viral 
load near delivery was undetectable in 89%, and CD4 count was ≥500 cells/L in 39% of pregnancies.  
About half of these pregnancies were conceived on cART. The median treatment duration among 
those initiating cART in pregnancy was 16 weeks (IQR: 13, 20 weeks). More than two-thirds of these 
pregnancies ended in a vaginal delivery, the majority of which were planned, and 12% of births were 
preterm (<37 weeks gestation) (Table 1). There were no significant differences in baseline 
characteristics of pregnancies between those with ROM ≥4 hours and those with ROM <4 hours, 
except for gestation (16.4% with ROM ≥4 hours were delivered preterm compared with 7.2% with 
ROM <4 hours, p<0.001) and mode of delivery (52.9% of pregnancies where ROM was ≥4 hours 
ended in vaginal delivery compared with 83.7% where ROM was <4 hours, p<0.01); the differences 
in gestation and mode of delivery were similar in the sub-group of pregnancies in women delivering 
with undetectable viral load [data not shown].   
Duration of ROM and MTCT in pregnancies delivered at term 
In the 88.2% of pregnancies delivered at term (2116/2398), median duration of ROM was 3 hours 30 
minutes (IQR: 1hr, 8hr); 11.2% (238/2116) of these deliveries had ROM duration reported as less 
than 15 minutes, 3.4% (71) greater than 24 hours, and 1.1% (24) greater than 48 hours. Figure 1 
shows the skewed distribution of ROM duration in pregnancies delivered at term. There was no 
annual trend in the proportion of pregnancies with duration of ROM ≥4 hours (p=0.60). 
Infection status was reported for 83% of term infants with delivery viral load available (1678/2032), 
with eight cases of mother-to-child transmission (MTCT rate 0.48%) (Table 2). The MTCT rate was 
0.13% among pregnancies delivered with undetectable viral load (2/1519); 2.05% with viral load 50-
999 copies/ml (3/146); and 23.1% with viral load ≥1000 copies/ml (3/13). The overall MTCT rate, 
regardless of delivery viral load, was not significantly different for pregnancies delivered at term with 
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ROM ≥4 hours (0.64%, 5/786) compared with those with ROM <4 hours (0.34%, 3/892, OR: 1.90; 
95% CI: 0.45, 7.97) (Table 2). Results were similar in term deliveries where viral load was <50 
copies/ml: the MTCT rate was 0.14% with ROM ≥4 hours and 0.12% with ROM <4 hours (Table 2) 
(OR: 1.14, 95% CI: 0.07, 18.27). In pregnancies delivered at term in women with undetectable viral 
load who had ROM ≥4 hours and <24 hours, the MTCT rate was 0.14% (2/1464), and there were no 
transmissions in the 55 pregnancies where duration of ROM was ≥24 hours.   
Timing of infant infection 
Term deliveries 
Eight infant infections were reported in term deliveries where infection status was reported 
(1678/2032). Two of these were in infants born to mothers delivering with an undetectable viral load 
(see Table 3; Cases 6 and 8) and timing of infant test results suggested intrapartum or postnatal 
transmission. In cases where maternal HIV viral load was detectable at delivery transmission most 
likely occurred in utero in three (Table 3; Cases 1-3), and in utero transmission could not be excluded 
in a further two (Cases 4 and 5). The other infected infant was born to a woman with high viral load 
and timing was likely intrapartum (Case 7). Excluding the three likely in utero transmissions, there 
was no evidence of a significant difference in MTCT rates in term deliveries at all viral loads, 
comparing ROM ≥4 with ROM <4 hours (0.38% (3/784), 0.22% (2/891) respectively, OR: 1.71, 95% CI: 
0.28, 10.25). Among those pregnancies with ROM <24 hours (excluding the in utero transmissions), 
the MTCT rate was 0.31% (5/1615), and there were no transmissions in the 60 deliveries with ROM 
≥24 hours. 
Preterm deliveries 
Among the 260 preterm infants, 45.1% (32/71) of those born at <34 weeks and 48.7% (92/189) of 
those born at 34-36 completed weeks gestation were delivered vaginally. Median duration of ROM 
was 7 hours (IQR 3, 15):  16 hours (IQR 2, 55) for deliveries at <34 weeks, and 6 hours (IQR 3, 11 
hours) for deliveries at 34-36 weeks gestation. Delivery viral load was <50 copies/ml in 75.4% 
(196/260) of these preterm deliveries, 51-999 copies/ml in 21.5% (56/260), and ≥1000 copies/ml in 
3.1% (8/260). Infection status was available for 84.6% (220/260) of preterm infants: the overall 
MTCT rate was 1.36% (3/220), and there were no transmissions with viral load <50 copies/ml. There 
was one transmission in 67 preterm deliveries with duration of ROM <4 hours, none in 121 with 
ROM 4 to <24 hours, and two transmissions in 34 with ROM ≥24 hours. Excluding the two likely in 
utero transmissions (see Table 3, Cases 9 and 10), there were no transmissions where ROM was <24 
hours, and one where ROM was ≥24 hours; this transmission occurred in an infant delivered by 
emergency caesarean section where maternal viral load was 50-399 copies/ml (Table 3; Case 11). 
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Missing data 
Overall, there was no significant difference between infants with known infection status and those 
where infection status was unreported in terms of the proportion with delivery viral load ≤50 
copies/ml (89% (1682/1900) versus 91% (356/392), p=0.62), or the proportion with ROM ≥4 hours 
(50% (941/1900) versus 51% (199/392), p=0.66). There was no significant difference in MTCT rate 
between the 4200 excluded pregnancies with infection status available (MTCT rate=0.57% (24/4200) 
and the study population of 1898 pregnancies with infection status available (MTCT= 0.58% 
(11/1898), p=0.93). 
Whether or not membranes were ruptured was not reported for 18% of pregnancies after exclusions 
(19% (126/665) in 2007 and 15% (109/747) in 2012, p<0.001). There was no significant difference in 
MTCT rates between pregnancies with duration of ROM reported and those where it was missing 
(0.56% (11/1978) with ROM duration reported vs 0.40% (7/1757) with missing ROM duration, 
p=0.49). There was also no significant difference between these groups in terms of viral load, CD4 
count, ethnic group, timing of HIV diagnosis, timing of cART initiation or mode of delivery [data not 
shown]. However there was a difference in the proportion of preterm deliveries between the two 
groups: 12% (282/2398) with ROM duration reported were preterm, compared with 22% (449/2025) 
of deliveries with missing ROM duration (p<0.001). 
 
Discussion and Conclusion  
Main Findings 
There was no evidence of an association between duration of ROM and MTCT in over 2000 
pregnancies in HIV-positive women on cART where data was available; in pregnancies delivered at 
term with an undetectable viral load the MTCT rate was 0.12% with ROM <4 hours and 0.14% with 
ROM ≥4 hours (OR: 1.14). Similarly, there was no evidence of an association between duration of 
ROM and MTCT in all term deliveries (i.e. including detectable and undetectable maternal viral 
loads). Overall, the MTCT rate was very low (0.46%), and similar to the rate of 0.57% recently 
reported for the cohort as a whole in the period 2007-11.1 The emergency caesarean section rate in 
pregnancies where membranes were ruptured was notable at around a third; the finding of no 
increased risk of MTCT in women with duration of ROM ≥4 hours supports a normalised approach to 
obstetric care in women taking cART who are in labour at term with ruptured membranes.  There 
was no evidence that the proportion of pregnancies with duration of ROM ≥4 hours had increased 
over the study period, which suggests that there were no substantial changes in practice or 
reporting characteristics over time. The 12% preterm birth rate was substantially higher than the 
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7.1% rate nationally,15 but similar to recently published data from the cohort as a whole,1 and in line 
with other European and American data on women on cART in pregnancy.16 
Strengths and Limitations 
Because of the high uptake of antenatal HIV screening17 and high study response rates [unpublished 
data, NSHPC], the majority of HIV positive pregnant women in the UK and Ireland are diagnosed 
prior to delivery and reported to our comprehensive surveillance study. To our knowledge this is the 
largest study to explore the effect of duration of ROM on MTCT rates in the cART era. Detailed 
reports are made to the study at several time points for each mother-child pair ensuring well-
reported data on ART, delivery characteristics, viral load and infant infection status, and enabling the 
sub-analysis of MTCT rates in women on cART with undetectable viral load; currently this is the only 
group in the UK for whom vaginal delivery is recommended.  
Due to very low MTCT rates in recent years, the number of infected children was small, precluding 
further subgroup analyses. Infection status was available for 83% of infants, with missing data largely 
due to reporting delay for more recent deliveries and not likely to result in substantial bias, as 
reported previously.1 In this analysis there was no significant difference, in terms of delivery viral 
load or duration of ROM, between infants with and without infection status reported. The small 
number of transmissions resulted in loss of precision in the estimates and wide confidence intervals 
for some of the calculated odds ratios. Similarly, small numbers in some sub-groups meant the data 
were not suitable for multivariable analyses. Furthermore the distribution of duration of ROM was 
highly skewed; ROM duration was therefore analysed as a categorical rather than a continuous 
variable. The proportion of missing data on duration of ROM decreased over time, probably due to 
gradually improving completion rates after the data field was added to reporting forms.   
Although transmissions classified as in utero most likely occurred before delivery (and before ROM) 
it is possible that transmission could have occurred at the time of delivery if duration of ROM was 
prolonged. However findings were similar whether or not these likely in utero transmissions were 
included. Clinical indications for emergency caesarean section were not considered in this analysis; 
this information was not well reported. Deliveries with duration of ROM ≥4 hours were more likely 
to be emergency caesarean sections than those with duration <4 hours. It is possible that some 
clinicians proceed to emergency caesarean section if duration of ROM is prolonged because of a 
perception of increased risk, although several studies have shown that caesarean section confers no 
benefit in terms of MTCT in women delivering with undetectable HIV viral load.1,18–20  However, 
longer duration of ROM may be associated with other obstetric indications for expediting delivery.    
Interpretation  
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These data from our national surveillance study confirm and strengthen previous findings that 
duration of ROM does not increase the risk of MTCT in women on cART.11,12 The emergency 
caesarean section rate for singleton live births among all diagnosed HIV-positive women delivering in 
2007-2011 was 24.7%,1 higher than the national rate for England of 14.4% in 2012-13.20  Our data 
provide further support for national guidelines which recommend that for HIV-positive women with 
undetectable viral load at term, obstetric management should follow the same principles as for the 
uninfected population.4   
Women living with HIV are at increased risk of preterm birth.21 There are no published data to 
inform the optimal management of women with preterm pre-labour rupture of membranes prior to 
34 weeks, and current guidelines recommend management on a case-by-case basis: the benefits of 
delaying labour weighed against the risk of MTCT.4 It is not possible to draw firm conclusions from 
the relatively small number of preterm deliveries in this analysis, although it is reassuring that there 
were no transmissions in pregnancies delivered preterm with an undetectable viral load despite the 
much longer duration of ROM in some of these cases, which was probably associated with the 
administration of corticosteroids.   
Conclusion  
MTCT does not appear to be associated with duration of ROM in HIV-positive women delivering at 
term on effective cART. As the normalisation of vaginal delivery for women with undetectable HIV 
viral load continues, we expect the number delivering with duration of ROM ≥4 hours to increase, 
and future analyses will be based on a larger population. This is especially important for exploring 
the relationship between gestation at onset of labour, duration of ROM and MTCT for women with 
preterm pre-labour ROM, who present obstetricians with the greatest challenge when deciding 
whether to delay delivery to optimise fetal maturation. In the current era of well-tolerated and 
highly effective ART, with an overall MTCT rate of 0.05% in women delivering on cART with an 
undetectable viral load,1 we are moving towards the goal of ensuring that women living with HIV 
who have fully suppressed viral load have the same obstetric options as their uninfected peers. 
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Table 1: Baseline characteristics of 2398 eligible* pregnancies in 1814 women delivered 2007-2012 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
  
 
 
 
 
 
 
*Singleton livebirths, delivered vaginally or by emergency caesarean section, in mothers diagnosed with HIV 
during or before pregnancy, on cART in pregnancy, membranes ruptured prior to delivery and duration of 
ROM reported.  
cART: combination antiretroviral therapy; ROM: rupture of membranes     
      
Characteristic N % 
Maternal age (years)   
<20 37 1.5 
20-29 799 33.3 
30-39 1426 59.5 
≥40 136 5.7 
   
Maternal ethnic group   
White 326 13.6 
Black African 1875 78.3 
Other 195 8.1 
   
Mode of acquisition    
       Heterosexual 2195 97.0 
       IDU-related 33 1.5 
       Other 34 1.5 
   
Timing of HIV diagnosis   
Before pregnancy 1779 74.2 
During pregnancy 619 25.8 
   
Viral load nearest delivery (copies/ml)   
<50 2038 88.9 
50-399 202 8.8 
400-999 29 1.3 
1000-9999 9 0.4 
  ≥10,000 14 0.6 
   
CD4 near delivery (cells/mm3)   
≥500 891 38.7 
350-499 752 32.6 
200-349 491 21.3 
<200 170 7.4 
   
Mode of delivery   
Emergency CS 757 31.6 
Planned vaginal 1569 65.4 
Unplanned Vaginal 72 3.0 
   
Gestation (completed weeks)   
<34  80 3.3 
34-36  202 8.4 
≥37 2116 88.2 
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Figure 1: Distribution of duration of ROM in women delivering at term with ROM <48 hours 
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Table 2: Mother-to-child transmission rates by duration of ROM among 1678 term deliveries (≥37 
weeks)  
 
 
 
 
 
 
 
 
ROM: rupture of membranes; VL: HIV viral load 
 1 Viral load <50 copies/ml 
 
 
Table 3: Cases of mother-to-child transmission in women delivering 2007-2012 with duration of 
rupture of membranes reported (ordered by gestation, timing of infection then maternal VL) 
 Gestation at 
delivery 
(weeks) 
Duration of 
ROM (hrs) 
Mode of 
delivery 
Maternal HIV 
VL (copies/ml) 
Likely timing of infant 
infection 
 
Term deliveries  
Case 1 ≥37 <4 Pl VD 50-399 In utero 
Case 2 ≥37 4 to <24 Em CS 50-399 In utero 
Case 3 ≥37 4 to <24 Unpl VD ≥10,000 In utero 
Case 4 ≥37 <4 Pl VD 50-399 In utero/intrapartum 
Case 5 ≥37 4 to <24 Em CS ≥10,000 In utero/intrapartum 
Case 6 ≥37 <4 Pl VD <50 Intrapartum 
Case 7 ≥37 4 to <24 Em CS ≥10,000 Intrapartum 
Case 8 ≥37 4 to <24 Pl VD <50 Intrapartum/postnatal 
 
Preterm deliveries 
Case 9 <34 ≥24 Unpl VD ≥10,000 In utero 
Case 10 34-36 <4 Em CS ≥10,000 In utero 
Case 11 34-36 ≥24 Em CS 50-399 Unknown  
 
ROM: rupture of membranes; Pl: planned; Unpl: unplanned; VD: vaginal delivery; Em: emergency; CS: 
caesarean section; VL: viral load 
Duration of ROM All infants 
delivered at term 
Infants delivered at term with 
suppressed maternal VL1   
<4 hour 0.34% (3/892) 0.12% (1/809) 
4 to <24 hour 0.69% (5/726) 0.15% (1/655) 
≥24 hours 0.00% (0/60) 0.00% (0/55) 
Total 0.48% (8/1678) 0.13% (2/1519) 
